Advertise with us
HomeNewsNAFDAC APPROVES CLINICAL TRIALS FOR THE USE OF CHLOROQUINE AGAINST COVID-19

NAFDAC APPROVES CLINICAL TRIALS FOR THE USE OF CHLOROQUINE AGAINST COVID-19

- Advertisement -
Advertise with us

The Director General of NAFDAC, Mojisola Adeyeye announced the approval of production of chloroquine for clinical trial against Covid -19.

The announcement was made today, Friday, 20 March 2020 at the NAFDAC Headquarters in Lagos.

She however warned that NAFDAC has not approved any drug including chloroquine for the treatment of the corona virus and that clinical trials and research is still ongoing.

She also emphasized that the medicine should not be used as anti- malaria because of the resistance that has been proven to develop from the use of chloroquine.

She encouraged researchers and experts who are interested in the clinical trials to approach NAFDAC.

Advertise with us
Oludare
Oludare
Lawyer, Bibliophile, Polyglot, Traveller
Advertise with us
Must Read
Advertise with us
Related News
Advertise with us

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.